reboxetine has been researched along with cyclohexanol in 35 studies
Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (cyclohexanol) | Trials (cyclohexanol) | Recent Studies (post-2010) (cyclohexanol) |
---|---|---|---|---|---|
626 | 193 | 184 | 4,548 | 691 | 1,355 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.86) | 18.2507 |
2000's | 25 (71.43) | 29.6817 |
2010's | 9 (25.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schatzberg, AF | 1 |
Kent, JM | 1 |
Devarajan, S; Dursun, SM | 1 |
Auclair, A; Gobert, A; Lejeune, F; Millan, MJ; Newman-Tancredi, A; Peglion, JL; Rivet, JM | 1 |
Brocco, M; Dekeyne, A; La Rochelle, CD; MacSweeny, C; Millan, MJ; Papp, M; Peglion, JL | 1 |
Manier, DH; Shelton, RC; Sulser, F | 1 |
Cohen, NL; Kennedy, SH; Lam, RW; Wan, DD | 1 |
Spence, D | 1 |
Alamo, C; López-Muñoz, F; Rubio, G; San, L | 1 |
Girardi, P; Kotzalidis, GD; Manfredi, G; Pacchiarotti, I; Ruberto, A; Tatarelli, R | 1 |
Dziedzicka-Wasylewska, M; Filip, M; Inan, SY; Przegaliński, E; Wydra, K | 1 |
Bertolín-Guillén, JM; Climent-Díaz, B; Navarré-Gimeno, A | 1 |
Gonzalez-Arriaza, HL; Krahn, LE | 1 |
Almási, J; Rihmer, Z | 1 |
Millan, MJ | 1 |
Amann, B; Hegerl, U; Juckel, G; Mergl, R; Mulert, C; Padberg, F; Pogarell, O; Sterr, A | 1 |
Akgoz, S; Akkaya, C; Kirli, S; Sarandol, A; Saygin Eker, S; Yazicioglu, B | 1 |
Akgoz, S; Akkaya, C; Eker, SS; Kirli, S; Sivrioglu, EY | 1 |
Butler, R; Carney, S; Cipriani, A; Geddes, J; Hatcher, S; Price, J; Von Korff, M | 1 |
Gannon, RL; Millan, MJ | 1 |
Källén, B; Lennestål, R | 1 |
Akkaya, C; Cangur, S; Eker, SS; Kirli, S; Sarandol, A; Sarandol, E | 1 |
Barnes, MJ; Cheng, FH; Daiss, JO; Mills, JS; Montana, JG; Naylor, RJ; Ngan, MP; Rudd, JA; Tacke, R; Wai, MK; Warneck, JB | 1 |
Bootzin, E; Millan, MJ; O'Donnell, JM; Zhang, HT; Zhao, Z | 1 |
Barrot, M; Doridot, S; Freund-Mercier, MJ; Hein, L; Petit-Demoulière, N; Tessier, LH; Yalcin, I | 1 |
Akkaya, C; Cangur, S; Eker, SS; Kirli, S; Sarandol, A | 1 |
Castro, E; Pazos, A; Valdizan, EM; Vidal, R; Vilaró, MT | 1 |
Fisar, Z; Hroudová, J; Raboch, J | 1 |
Charoenphandhu, J; Charoenphandhu, N; Krishnamra, N; Lapmanee, S | 1 |
Charoenphandhu, J; Charoenphandhu, N; Krishnamra, N; Lapmanee, S; Teerapornpuntakit, J | 1 |
Barbui, C; Churchill, R; Cipriani, A; Furukawa, TA; Imperadore, G; Purgato, M; Signoretti, A; Trespidi, C; Watanabe, N | 1 |
Eriksson, AC; Hägg, S; Hallbäck, I; Whiss, PA | 1 |
Charoenphandhu, J; Charoenphandhu, N; Lapmanee, S | 1 |
Barak, Y; Baratz-Goldstein, R; Hostovsky, A; Pick, CG; Rubovitch, V; Schreiber, S; Volis, I | 1 |
Gray, VC; Hughes, RN | 1 |
7 review(s) available for reboxetine and cyclohexanol
Article | Year |
---|---|
Antidepressant effectiveness in severe depression and melancholia.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Humans; Morpholines; Reboxetine; Research Design; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Morpholines; Piperazines; Reboxetine; Structure-Activity Relationship; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2000 |
Combining antidepressants for treatment-resistant depression: a review.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Humans; Mianserin; Monoamine Oxidase Inhibitors; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Research Design; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
[Review of antidepressants from the TCAs to the third generation drugs].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Drug Combinations; Duloxetine Hydrochloride; Humans; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Morpholines; Piperazines; Pyrimidines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Trazodone; Triazoles; Venlafaxine Hydrochloride | 2004 |
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Brain; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Dopamine; Dopamine Uptake Inhibitors; Drug Delivery Systems; Drug Design; Drug Therapy, Combination; Humans; Morpholines; Nerve Net; Neurons; Norepinephrine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2006 |
Depression in adults.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Electroconvulsive Therapy; Humans; Hypericum; Monoamine Oxidase Inhibitors; Morpholines; Phytotherapy; Plant Preparations; Psychotherapy; Reboxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
Citalopram versus other anti-depressive agents for depression.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depression; Humans; Morpholines; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2012 |
5 trial(s) available for reboxetine and cyclohexanol
Article | Year |
---|---|
Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms.
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Morpholines; Reboxetine; Venlafaxine Hydrochloride | 2001 |
Reboxetine adjunct for partial or nonresponders to antidepressant treatment.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Dysthymic Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Personality Inventory; Prospective Studies; Reboxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
A comparison of the efficacy and tolerability of reboxetine and sertraline versus venlafaxine in major depressive disorder: a randomized, open-labeled clinical trial.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Cyclohexanols; Depressive Disorder, Major; Drug Evaluation; Drug Interactions; Female; Humans; Male; Middle Aged; Morpholines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Venlafaxine Hydrochloride | 2006 |
Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Severity of Illness Index; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Effects of various antidepressants on serum thyroid hormone levels in patients with major depressive disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thyroid Hormones; Venlafaxine Hydrochloride | 2008 |
23 other study(ies) available for reboxetine and cyclohexanol
Article | Year |
---|---|
S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
Topics: Animals; Brain Chemistry; Carrier Proteins; Citalopram; Clomipramine; Cyclohexanols; Electrophysiology; Humans; Ligands; Male; Membrane Glycoproteins; Membrane Transport Proteins; Morpholines; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; p-Chloroamphetamine; Rats; Rats, Wistar; Reboxetine; Receptors, Adrenergic, alpha; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Symporters; Venlafaxine Hydrochloride | 2001 |
S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Body Temperature; Carrier Proteins; Citalopram; Clomipramine; Cyclohexanols; Discrimination, Psychological; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Morpholines; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; p-Chloroamphetamine; Postural Balance; Rats; Rats, Wistar; Reaction Time; Reboxetine; Reserpine; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Symporters; Venlafaxine Hydrochloride | 2001 |
Noradrenergic antidepressants: does chronic treatment increase or decrease nuclear CREB-P?
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cell Nucleus; Cells, Cultured; Cerebral Cortex; Cyclic AMP Response Element-Binding Protein; Cyclohexanols; Desipramine; Fibroblasts; Humans; Male; Morpholines; Rats; Rats, Sprague-Dawley; Reboxetine; Time Factors; Venlafaxine Hydrochloride | 2002 |
Management of anorexia nervosa revisited: drug treatment suggestions are questionable.
Topics: Anorexia Nervosa; Antidepressive Agents; Cyclohexanols; Humans; Morpholines; Reboxetine; Venlafaxine Hydrochloride | 2004 |
A case of social phobia and avoidant personality disorder with erectile dysfunction successfully treated with venlafaxine and add-on reboxetine.
Topics: Adult; Cyclohexanols; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Morpholines; Personality Disorders; Phobic Disorders; Reboxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2004 |
Opioid and monoamine systems mediate the discriminative stimulus of tramadol in rats.
Topics: Adrenergic Uptake Inhibitors; Analgesics, Opioid; Animals; Antidepressive Agents; Biogenic Monoamines; Conditioning, Operant; Cyclohexanols; Cyclopropanes; Discrimination, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Male; Milnacipran; Morphine; Morpholines; Naloxone; Narcotic Antagonists; Nomifensine; Rats; Rats, Wistar; Reboxetine; Receptors, Opioid, mu; Selective Serotonin Reuptake Inhibitors; Sodium Chloride; Tramadol; Venlafaxine Hydrochloride | 2004 |
Serotonin syndrome due to association of venlafaxine, maprotiline and reboxetine.
Topics: Cyclohexanols; Depressive Disorder; Emergency Medical Services; Humans; Male; Maprotiline; Middle Aged; Morpholines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2004 |
Narcolepsy with cataplexy.
Topics: Adult; Cataplexy; Comorbidity; Cyclohexanols; Hallucinations; Humans; Male; Morpholines; Narcolepsy; Patient Education as Topic; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sodium Oxybate; Venlafaxine Hydrochloride | 2004 |
Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline.
Topics: Adult; Amitriptyline; Antidepressive Agents; Cerebral Cortex; Citalopram; Cyclohexanols; Electroencephalography; Epilepsy; Female; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Morpholines; Reboxetine; Venlafaxine Hydrochloride | 2006 |
Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms.
Topics: Adrenergic Uptake Inhibitors; Animals; Bupropion; Circadian Rhythm; Cricetinae; Cyclohexanols; Dopamine Uptake Inhibitors; Light; Male; Mesocricetus; Morpholines; Motor Activity; Reboxetine; Running; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2007 |
Delivery outcome in relation to maternal use of some recently introduced antidepressants.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adrenergic Uptake Inhibitors; Antidepressive Agents; Birth Weight; Cyclohexanols; Databases, Factual; Delivery, Obstetric; Female; Gestational Age; Humans; Infant Mortality; Infant, Newborn; Mianserin; Mirtazapine; Morpholines; Pregnancy; Pregnancy Trimester, First; Prenatal Exposure Delayed Effects; Reboxetine; Registries; Selective Serotonin Reuptake Inhibitors; Smoking; Sweden; Venlafaxine Hydrochloride | 2007 |
Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret.
Topics: Adrenergic Uptake Inhibitors; Animals; Antiemetics; Antineoplastic Agents; Apomorphine; Cisplatin; Cyclohexanols; Ferrets; Male; Morpholines; Reboxetine; Serotonin Antagonists; Venlafaxine Hydrochloride; Vomiting | 2008 |
Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain; Cyclohexanols; Depression; Down-Regulation; Fenclonine; Male; Monoamine Oxidase Inhibitors; Morpholines; Norepinephrine Plasma Membrane Transport Proteins; Phenelzine; Protein Synthesis Inhibitors; Protriptyline; Rats; Rats, Sprague-Dawley; Reboxetine; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Sertraline; Venlafaxine Hydrochloride | 2009 |
Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amines; Animals; Anticonvulsants; Antidepressive Agents; Cyclohexanecarboxylic Acids; Cyclohexanols; Desipramine; Gabapentin; gamma-Aminobutyric Acid; Male; Mice; Mice, Transgenic; Morpholines; Pain; Pain Threshold; Propanolamines; Reboxetine; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta-2; Sciatic Nerve; Venlafaxine Hydrochloride; Yohimbine | 2009 |
Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?
Topics: Adrenergic Uptake Inhibitors; Adult; Age Factors; Antidepressive Agents; Climacteric; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Middle Aged; Morpholines; Personality Inventory; Reboxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride; Young Adult | 2009 |
Reduced signal transduction by 5-HT4 receptors after long-term venlafaxine treatment in rats.
Topics: Action Potentials; Adenylyl Cyclases; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Benzamides; Brain; Bridged Bicyclo Compounds, Heterocyclic; CA1 Region, Hippocampal; Cyclohexanols; Drug Interactions; Male; Morpholines; Pyramidal Cells; Radioligand Assay; Rats; Rats, Wistar; Reboxetine; Receptors, Serotonin, 5-HT4; Signal Transduction; Venlafaxine Hydrochloride | 2010 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |
Anxiolytic-like actions of reboxetine, venlafaxine and endurance swimming in stressed male rats.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Cyclohexanols; Male; Morpholines; Motor Activity; Physical Conditioning, Animal; Rats; Rats, Wistar; Reboxetine; Restraint, Physical; Stress, Physiological; Stress, Psychological; Swimming; Venlafaxine Hydrochloride | 2012 |
Duodenal calcium transporter mRNA expression in stressed male rats treated with diazepam, fluoxetine, reboxetine, or venlafaxine.
Topics: Animals; Calcium; Calcium Channels; Cyclohexanols; Diazepam; Duodenum; Fluoxetine; Gene Expression Regulation; Ion Transport; Male; Morpholines; Rats; Reboxetine; Restraint, Physical; RNA, Messenger; Venlafaxine Hydrochloride | 2012 |
In vitro effects of serotonin and noradrenaline reuptake inhibitors on human platelet adhesion and coagulation.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Blood Coagulation; Blood Platelets; Citalopram; Cyclohexanols; Female; Fibrinogen; Humans; Male; Middle Aged; Morpholines; Norepinephrine; Platelet Adhesiveness; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Venlafaxine Hydrochloride; Young Adult | 2012 |
Beneficial effects of fluoxetine, reboxetine, venlafaxine, and voluntary running exercise in stressed male rats with anxiety- and depression-like behaviors.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Cyclohexanols; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Male; Maze Learning; Morpholines; Physical Conditioning, Animal; Rats; Rats, Wistar; Reboxetine; Restraint, Physical; Running; Stress, Psychological; Sucrose; Swimming; Venlafaxine Hydrochloride | 2013 |
Interaction of different antidepressants with acute and chronic methadone in mice, and possible clinical implications.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Citalopram; Clomipramine; Cyclohexanols; Desipramine; Drug Interactions; Fluvoxamine; Male; Methadone; Mice; Mice, Inbred ICR; Morpholines; Nociception; Pain Threshold; Reboxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2014 |
Drug-, dose- and sex-dependent effects of chronic fluoxetine, reboxetine and venlafaxine on open-field behavior and spatial memory in rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Cyclohexanols; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Fluoxetine; Locomotion; Male; Maze Learning; Memory, Short-Term; Morpholines; Motor Activity; Rats; Rats, Inbred Strains; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sex Factors; Spatial Memory; Time Factors; Venlafaxine Hydrochloride | 2015 |